PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPerindopril erbumine
Perindopril erbumine
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
96 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I10—37201747
Essential hypertensionD000075222—I10——4239
Cardiovascular diseasesD002318EFO_0000319I98—12126
Type 2 diabetes mellitusD003924EFO_0001360E11——14—5
Diabetes mellitusD003920EFO_0000400E08-E13——2215
Covid-19D000086382—U07.1——2114
Chronic renal insufficiencyD051436—N18———314
Kidney diseasesD007674EFO_0003086N08———314
Heart failureD006333EFO_0003144I5011—214
SyndromeD013577————1214
Show 28 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
RecurrenceD012008————1—23
Vascular diseasesD014652EFO_0004264I77——1—12
PneumoniaD011014EFO_0003106J18——1——1
AlbuminuriaD000419EFO_0004285R80.9——1——1
CardiomyopathiesD009202EFO_0000318I42——1——1
Dilated cardiomyopathyD002311EFO_0000407I42.0——1——1
Non-small-cell lung carcinomaD002289————1——1
Lung neoplasmsD008175—C34.90——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AgingD000375GO_0007568R41.81—1——12
Breast neoplasmsD001943EFO_0003869C5012———2
Ischemic strokeD000083242———1——12
StrokeD020521EFO_0000712I63.9—1——12
ObesityD009765EFO_0001073E66.9—1——12
Sedentary behaviorD057185———1———1
Alzheimer diseaseD000544EFO_0000249F03—1———1
Transient ischemic attackD002546EFO_0003764G45.9—1———1
Abdominal aortic aneurysmD017544EFO_0004214——1———1
AneurysmD000783—I72.9—1———1
Show 3 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———4———15
Therapeutic equivalencyD013810——4————4
Substance-related disordersD019966EFO_0003890F131————1
Post-traumatic stress disordersD013313EFO_0001358F43.11————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cognitive dysfunctionD060825—G31.84————22
Metabolic bone diseasesD001851——————11
Medication adherenceD055118EFO_0006344—————11
Patient participationD010358——————11
Coronary diseaseD003327——————11
Subdural hematomaD006408——————11
HematomaD006406EFO_0010680—————11
Subdural hematoma chronicD020200——————11
Cardio-renal syndromeD059347——————11
Ovarian neoplasmsD010051EFO_0003893C56————11
Show 1 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 144 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,915 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use